BIOSTATISTICS SHARED RESOURCE GROUP
生物统计共享资源组
基本信息
- 批准号:8695824
- 负责人:
- 金额:$ 12.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressApplications GrantsAwardAwarenessBiometryBiostatistics Shared ResourceCancer CenterCancer Center Support GrantClinical ResearchClinical TrialsClinical Trials DesignCollaborationsComputer softwareDataData QualityDevelopmentEducationEffectivenessEnsureFacultyFundingGoalsImmunoassayJournalsLeadershipManuscriptsMedicalMethodologyMissionMonitorNCI Center for Cancer ResearchPhasePreparationProductivityProtocols documentationPublicationsQuality ControlRecordsReportingResearchResearch DesignResearch PersonnelResource SharingResourcesReview CommitteeSafetyServicesSouth CarolinaStatistical MethodsSystemTrainingUniversitiesValidity and Reliabilityanticancer researchbasecost effectivedesignexpectationinnovationlecturesmeetingsmembernoveloncologyoperationprogramsresearch studysuccess
项目摘要
The mission of the Biostatistics Shared Resource (BSR) is to provide outstanding biostatistics leadership and support in a cost-effective manner for the Hollings Cancer Center (HCC) and to act as a hub that facilitates interactions among the various investigators, other shared resources, and programs within the HCC. Under the leadership of Dr. Elizabeth Garrett-Mayer, the BSR is composed of biostatisticians with in-depth training in cancer research and oncology and complementary expertise in the various approaches used in these endeavors. Dr. Garrett-Mayer utilizes a team-based approach to accomplish the goals of the resource. The success and effectiveness of the HCC BSR are demonstrated by the extent of collaborations since the CCSG was awarded in 2009, resulting in the development of 89 ROI applications and an additional 239 other grant applications {e.g., POI, DOD, T32) through the end of 2012; submission and/or publication of more than 100 manuscripts with BSR members as co-authors; and development of 48 investigator-initiated clinical research studies.
The purposes of the BSR are to:
* Provide statistical support to HCC investigators for the design of studies, analysis of data, quality
control, manuscript preparation, and development of competitive grant proposals.
* Adapt, develop, and validate novel statistical methodologies to address emerging approaches in
ongoing HCC research.
* Facilitate interactions within the HCC by participating in project development meetings with program
leaders and other shared resource directors.
* Serving on the HCC Protocol Review Committee and Data & Safety Monitoring Committee to provide
critical input into proposed and ongoing internal and external clinical trials.
* Provide ongoing education in statistical methods and approaches for faculty, fellows, residents and staff
of the HCC.
生物统计学共享资源(BSR)的使命是以具有成本效益的方式为Hollings癌症中心(HCC)提供出色的生物统计学领导和支持,并作为促进HCC内各种研究者、其他共享资源和项目之间互动的中心。在Elizabeth Garrett-Mayer博士的领导下,BSR由在癌症研究和肿瘤学方面接受过深入培训的生物统计学家组成,并在这些工作中使用的各种方法方面具有互补的专业知识。Garrett-Mayer博士利用基于团队的方法来实现资源的目标。自2009年获得CCSG以来,合作的程度证明了HCC BSR的成功和有效性,导致开发了89个ROI应用程序和另外239个其他赠款应用程序(例如,POI、DOD、T32);提交和/或出版了100多篇与BSR成员共同撰写的手稿;开发了48项由制药商发起的临床研究。
BSR的目的是:
* 为HCC研究者提供研究设计、数据分析、质量
控制,手稿准备,并制定有竞争力的赠款提案。
* 调整、开发和验证新的统计方法,以解决以下方面的新兴方法:
正在进行的HCC研究。
* 通过参加项目开发会议,促进HCC内部的互动,
领导者和其他共享资源主管。
* 担任HCC方案审查委员会和数据与安全监测委员会的成员,
对拟议和正在进行的内部和外部临床试验的关键输入。
* 为教师、研究员、住院医师和工作人员提供统计方法和方法方面的持续教育
的HCC。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew S Kraft其他文献
Andrew S Kraft的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew S Kraft', 18)}}的其他基金
Regulation of RNA Decapping and Degradation: A novel approach to prostate cancer therapy
RNA 脱帽和降解的调控:前列腺癌治疗的新方法
- 批准号:
10758110 - 财政年份:2023
- 资助金额:
$ 12.18万 - 项目类别:
Pim 1 Protein Kinase in Regulating Stromal Cell Biology in Prostate Cancer
Pim 1 蛋白激酶调节前列腺癌基质细胞生物学
- 批准号:
8855025 - 财政年份:2015
- 资助金额:
$ 12.18万 - 项目类别:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
MUSC/HCC Paul Calabresi 临床肿瘤学培训计划计划
- 批准号:
8486908 - 财政年份:2013
- 资助金额:
$ 12.18万 - 项目类别:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
靶向 Pim 1 蛋白激酶以克服对 AKT 抑制剂的耐药性
- 批准号:
8735893 - 财政年份:2013
- 资助金额:
$ 12.18万 - 项目类别:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
靶向 Pim 1 蛋白激酶以克服对 AKT 抑制剂的耐药性
- 批准号:
8577635 - 财政年份:2013
- 资助金额:
$ 12.18万 - 项目类别:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
靶向 Pim 1 蛋白激酶以克服对 AKT 抑制剂的耐药性
- 批准号:
9039263 - 财政年份:2013
- 资助金额:
$ 12.18万 - 项目类别:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
靶向 Pim 1 蛋白激酶以克服对 AKT 抑制剂的耐药性
- 批准号:
9320825 - 财政年份:2013
- 资助金额:
$ 12.18万 - 项目类别:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
靶向 Pim 1 蛋白激酶以克服对 AKT 抑制剂的耐药性
- 批准号:
8891388 - 财政年份:2013
- 资助金额:
$ 12.18万 - 项目类别: